Nisotirotide (LY-3457263) is a PYY analog agonist studied in type 2 diabetes and obesity.
References:
[1]. Kloock S, et al. Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery Pharmacol Ther. 2023 Nov;251:108549.
















